A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Clinical trial NCT01986855 · COMPLETED
Trial details
- NCT number
- NCT01986855
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2016-09-28
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.